KR0138262B1 - 5'-인돌리닐-5β-아미도메틸옥사졸리딘-2-온, 3-(융합-고리치환된)페닐-5β-아미도메틸옥사졸리딘-2-온 및 3-(질소 치환된) 페닐-5β-아미도메틸옥사졸리딘-2-온 - Google Patents

5'-인돌리닐-5β-아미도메틸옥사졸리딘-2-온, 3-(융합-고리치환된)페닐-5β-아미도메틸옥사졸리딘-2-온 및 3-(질소 치환된) 페닐-5β-아미도메틸옥사졸리딘-2-온

Info

Publication number
KR0138262B1
KR0138262B1 KR1019900701012A KR900701012A KR0138262B1 KR 0138262 B1 KR0138262 B1 KR 0138262B1 KR 1019900701012 A KR1019900701012 A KR 1019900701012A KR 900701012 A KR900701012 A KR 900701012A KR 0138262 B1 KR0138262 B1 KR 0138262B1
Authority
KR
South Korea
Prior art keywords
oxazolidin
acetamidomethyl
alkyl
mixture
mhz
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019900701012A
Other languages
English (en)
Korean (ko)
Other versions
KR900701780A (ko
Inventor
제이 브릭크너 스티븐
Original Assignee
로렌스 티. 웰츠
팔마샤 앤드 업죤 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로렌스 티. 웰츠, 팔마샤 앤드 업죤 캄파니 filed Critical 로렌스 티. 웰츠
Publication of KR900701780A publication Critical patent/KR900701780A/ko
Application granted granted Critical
Publication of KR0138262B1 publication Critical patent/KR0138262B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019900701012A 1988-09-15 1990-05-15 5'-인돌리닐-5β-아미도메틸옥사졸리딘-2-온, 3-(융합-고리치환된)페닐-5β-아미도메틸옥사졸리딘-2-온 및 3-(질소 치환된) 페닐-5β-아미도메틸옥사졸리딘-2-온 Expired - Fee Related KR0138262B1 (ko)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US24498888A 1988-09-15 1988-09-15
US07/244,988 1988-09-15
US7/244,988 1988-09-15
US25385088A 1988-10-05 1988-10-05
US7/253,850 1988-10-05
US32494289A 1989-03-17 1989-03-17
US07/324,942 1989-03-17
US7/324,942 1989-03-17
PCT/US1989/003548 WO1990002744A1 (en) 1988-09-15 1989-08-22 In position 3 substituted-5-beta-amidomethyl-oxazolidin-2-ones
US07/253,850 1989-10-05

Publications (2)

Publication Number Publication Date
KR900701780A KR900701780A (ko) 1990-12-04
KR0138262B1 true KR0138262B1 (ko) 1998-05-15

Family

ID=27399816

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900701012A Expired - Fee Related KR0138262B1 (ko) 1988-09-15 1990-05-15 5'-인돌리닐-5β-아미도메틸옥사졸리딘-2-온, 3-(융합-고리치환된)페닐-5β-아미도메틸옥사졸리딘-2-온 및 3-(질소 치환된) 페닐-5β-아미도메틸옥사졸리딘-2-온

Country Status (14)

Country Link
EP (3) EP0359418B1 (https=)
JP (2) JP2865211B2 (https=)
KR (1) KR0138262B1 (https=)
AT (2) ATE201870T1 (https=)
AU (1) AU617871B2 (https=)
CA (1) CA1335103C (https=)
DE (2) DE68929303T2 (https=)
DK (2) DK175696B1 (https=)
ES (1) ES2157934T3 (https=)
GR (1) GR3036491T3 (https=)
HK (1) HK1002234A1 (https=)
LV (1) LV12888B (https=)
TW (1) TW219936B (https=)
WO (1) WO1990002744A1 (https=)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231188A (en) * 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
JPH06510285A (ja) * 1991-08-14 1994-11-17 プロクター、エンド、ギャンブル、ファーマスーティカルズ、インコーポレーテッド 抗不整脈及び抗細動剤として有用な環状ウレタン類
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
KR950702417A (ko) * 1992-07-08 1995-07-29 로렌스 티. 웰츠 마이코박테륨 투베르쿨로시스에 대해 유용한 5′-인돌리닐 옥사졸리디논(5′-indolinyl oxazolidinones useful against mycobacterium tuberculosis)
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
DE4425609A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
DE19514313A1 (de) * 1994-08-03 1996-02-08 Bayer Ag Benzoxazolyl- und Benzothiazolyloxazolidinone
JP3933198B2 (ja) * 1994-10-26 2007-06-20 ファルマシア・アンド・アップジョン・カンパニー フェニルオキサゾリジノン抗菌剤
BR9509673A (pt) * 1994-11-15 1997-09-30 Upjohn Co Compostos e uso dos mesmos
DK0807112T3 (da) * 1995-02-03 2001-12-17 Upjohn Co Antimikrobiel heteroaromatisk ringsubstitueret phenyloxazolidinon
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
NZ306310A (en) * 1995-05-11 2001-05-25 Upjohn Co Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
US5883093A (en) * 1995-09-12 1999-03-16 Pharmacia & Upjohn Company Phenyloxazolidinone antimicrobials
ZA968661B (en) * 1995-11-17 1998-04-14 Upjohn Co Oxazolidinone antibacterial agent with tricyclic substituents.
DE19601264A1 (de) 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19601265A1 (de) 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
DE19601627A1 (de) * 1996-01-18 1997-07-24 Bayer Ag Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
HRP970049A2 (en) 1996-02-06 1998-04-30 Bayer Ag New heteroaryl oxazolidinones
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
US6255304B1 (en) 1997-05-30 2001-07-03 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
CN1138765C (zh) 1997-05-30 2004-02-18 法玛西雅厄普约翰美国公司 带有硫代羰基功能基的噁唑烷酮抗菌剂
DE19730847A1 (de) * 1997-07-18 1999-01-28 Bayer Ag Tricyclisch substituierte Oxazolidinone
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
BR9813985A (pt) * 1997-11-12 2000-09-26 Upjohn Co Derivados de oxazolidinona e composições farmacêuticas
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
DE19802239A1 (de) * 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
KR20010015910A (ko) * 1998-01-23 2001-02-26 로렌스 티. 마이젠헬더 옥사졸리디논 조합 라이브러리, 조성물 및 제조 방법
ES2203473T3 (es) * 1999-05-27 2004-04-16 PHARMACIA & UPJOHN COMPANY Oxazolidinonas biciclicas como agentes antibacterianos.
US6441005B1 (en) 1999-07-28 2002-08-27 Pharmacia & Upjohn Company Oxazolidinone compounds and compositions, and methods of using the same
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
BR0112826A (pt) 2000-07-17 2003-06-24 Ranbaxy Lab Ltd Derivados da oxazolidinona como antimicrobianos
JP4269144B2 (ja) 2000-10-02 2009-05-27 エモリー ユニバーシティ 自己免疫疾患および炎症障害の処置のためのトリプトリドアナログ
PE20020689A1 (es) * 2000-11-17 2002-08-03 Upjohn Co Oxazolidinonas con un heterociclo de 6 o 7 miembros unidos con enlace anular al benceno
US6956040B2 (en) 2001-07-16 2005-10-18 Ranbaxy Laboratories Limited Oxazolidinone piperazinyl derivatives as potential antimicrobials
GB0118407D0 (en) * 2001-07-27 2001-09-19 Cipla Ltd Oxazolidinone derivatives as antibacterial agents
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
MX2007001526A (es) * 2004-08-06 2007-03-27 Pharmacia & Upjohn Co Llc Oxazolidinonas que contienen oxindoles como agentes antibacterianos.
SE0402763D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Nitro indazole derivatives
MX2007011873A (es) * 2005-04-06 2007-11-07 Pharmacia & Upjohn Co Llc Una oxindoloxazolidinona como agente antibacteriano.
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
AU2008339607B2 (en) * 2007-12-24 2012-08-02 Cipla Limited Process for the synthesis of propargylated aminoindan derivatives
CA2794153C (en) 2010-03-25 2018-01-02 Glaxosmithkline Llc Substituted indoline derivatives as perk inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8506659A1 (es) * 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
CA1260948A (en) * 1984-12-05 1989-09-26 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents

Also Published As

Publication number Publication date
AU617871B2 (en) 1991-12-05
CA1335103C (en) 1995-04-04
DE68918792D1 (de) 1994-11-17
HK1002234A1 (en) 1998-08-07
DK200401246A (da) 2004-08-18
LV12888B (en) 2002-12-20
ATE201870T1 (de) 2001-06-15
WO1990002744A1 (en) 1990-03-22
EP0434714A1 (en) 1991-07-03
ATE112773T1 (de) 1994-10-15
DE68929303T2 (de) 2002-05-02
EP0609905A1 (en) 1994-08-10
ES2157934T3 (es) 2001-09-01
JPH1180139A (ja) 1999-03-26
DE68918792T2 (de) 1995-03-30
DE68929303D1 (de) 2001-07-12
EP0609905B1 (en) 2001-06-06
GR3036491T3 (en) 2001-11-30
JP3188418B2 (ja) 2001-07-16
KR900701780A (ko) 1990-12-04
JPH04500665A (ja) 1992-02-06
TW219936B (https=) 1994-02-01
DK175696B1 (da) 2005-01-24
EP0359418B1 (en) 1994-10-12
DK45591D0 (da) 1991-03-13
DK175940B1 (da) 2005-08-01
EP0359418A1 (en) 1990-03-21
AU4195789A (en) 1990-04-02
JP2865211B2 (ja) 1999-03-08
DK45591A (da) 1991-03-13

Similar Documents

Publication Publication Date Title
KR0138262B1 (ko) 5'-인돌리닐-5β-아미도메틸옥사졸리딘-2-온, 3-(융합-고리치환된)페닐-5β-아미도메틸옥사졸리딘-2-온 및 3-(질소 치환된) 페닐-5β-아미도메틸옥사졸리딘-2-온
US5164510A (en) 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
US5182403A (en) Substituted 3(5'indazolyl) oxazolidin-2-ones
US5225565A (en) Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
US5801246A (en) Substituted heteroarylphenyloxazolidinones
HK1002234B (en) 5'-indolinyl-5beta-amidomethyloxazolidin-2-ones, 3-(fused-ring substituted)phenyl-5beta-amidomethy-loxazolidin-2-ones and 3-(nitrogen substituted)phenyl-5beta-amidomethyloxazolidin-2-ones
JP3628329B2 (ja) オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
US5688792A (en) Substituted oxazine and thiazine oxazolidinone antimicrobials
JPS61134379A (ja) アミノメチルオキソオキサゾリジニルベンゼン誘導体
RU2215740C2 (ru) Оксазолидиноновые производные и фармацевтические композиции на их основе
EP2429998B1 (fr) Dérivés de cyclopenta[c]pyrrolylalkylcarbamates d'hétérocycles à 5 chaînons, leur préparation et leur application en thérapeutique
JPH0784446B2 (ja) 新規な置換チアゾ−ルおよびオキサゾ−ル化合物
EP0648119A1 (en) 5'-INDOLINYL OXAZOLIDINONES USEFUL AGAINST $i(MYCOBACTERIUM TUBERCULOSIS)
US6365612B2 (en) Benzosultam oxazolidinone antibacterial agents
WO1991007409A1 (en) Tricyclic [6,5,5]/[6,6,5]-fused oxazolidinone antibacterial agents
JP2000229978A (ja) オキサゾリジノン及び抗菌剤としてのそれらの使用
JPH02502455A (ja) ピリドンカルボン酸または酸誘導体を含有する抗生物質β‐ラクタム
KR19980084677A (ko) 옥사졸리디논 유도체, 이의 제조방법 및 그를 함유한 항균제 조성물
KR100467309B1 (ko) 옥사졸리디논유도체및그의제조방법및항균제조성물
TW200413360A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
KR100530017B1 (ko) 옥사졸리디논 유도체 화합물 및 그의 제조방법 및 그를 함유하는 항균제 조성물
HK1187918B (en) Oxazoline and isoxazoline derivatives as crac modulators
HK1052339A (en) Novel benzosultam oxazolidinone antibacterial agents

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20050201

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20060218

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20060218

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000